ReviewFrontiers in neurology
Rethinking the classification of acute status epilepticus: structural brain vs. systemic etiologies.
Review in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Associations between duration of status epilepticus and clinical outcomes in adults: a systematic review.Journal of neurology · 2026Pooled it
- Treatment adequacy outweighs treatment sequence in non-convulsive status epilepticus.Epilepsia · 2026Article
- Post-stroke seizures: classification, risk prediction, and management.Frontiers in neurology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Status epilepticus (SE) is a life-threatening neurological emergency whose modern conceptualization employs a multidimensional framework encompassing semiology, etiology, electroencephalographic features, and age. Among these, the etiological dimension is central, as it captures the underlying pathophysiology and critically informs both acute management and long-term prognosis. Current classifications define acute SE by its temporal proximity to a central nervous system insult, yet this approach groups heterogeneous mechanisms under a single category. Acute SE arising from structural brain injury involves downstream receptor and ionic dysfunction driven by inflammation, neuronal loss, glial activation, and network remodeling. In contrast, systemic etiologies, such as electrolyte disturbances, toxic exposures, or withdrawal states, primarily reflect transient disruptions in excitatoryinhibitory balance or ionic homeostasis. These mechanistic distinctions translate into meaningful clinical differences: structural causes are associated with higher mortality, greater seizure recurrence, and an increased risk of subsequent epilepsy. A more refined etiological classification distinguishing structural from systemic causes could better capture variations in pathophysiology, treatment response, and long-term outcomes. Such a framework may also guide decisions regarding the duration and intensity of antiseizure medication (ASM) therapy, a domain in which evidence remains limited. Whether early and sustained ASM treatment after SE due to structural brain injury can modify epileptogenesis is unknown, as no randomized controlled trials have directly addressed this question. Clarifying etiological subgroups may therefore facilitate targeted clinical and translational studies, improve prognostication, and ultimately support the development of interventions to prevent the transition from acute SE to chronic epilepsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.